3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase NA
3
Phase 1
3
Phase 3
2
Phase 1/2
2
Phase EARLY_PHASE1
1
Phase 4
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
3
Neoplasms
2
Skin Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Kidney Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Sirolimus
3
aldesleukin
2
Tacrolimus
2
Cyclosporine
2
relatlimab
1
oxycodone-acetaminophen
1
abobotulinumtoxinA
1
Vemurafenib
1
Sodium Chloride
1
Prednisone
1
Nivolumab
1
Mycophenolic Acid
1
Meloxicam
1
Ipilimumab
1
Interleukins
1
Interleukin-2
1
Fluorouracil
1
Everolimus
1
Bleomycin
1
Azathioprine
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Skin Neoplasms
×
Ipilimumab
×
Clear all
NCT01856023
2023-12-05
PROCLIVITY02
Clinigen, Inc.
Phase 4
Terminated
29 enrolled
9 charts